Effective Feedback to Improve Primary Care Prescribing Safety (EFIPPS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01602705 |
Recruitment Status :
Completed
First Posted : May 21, 2012
Last Update Posted : October 7, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
We hypothesise that feedback and feedback + psychology informed intervention delivered to primary care medical practices will reduce high-risk prescribing to patients compared to a simple educational intervention alone. The specific objectives are :
- To test the effectiveness of the two EFIPPS feedback arms in reducing the specified primary outcome of a composite measure of high-risk antipsychotic, non-steroidal anti-inflammatory drug, and antiplatelet drug prescribing
- To test the effectiveness of the two EFIPPS feedback arms in reducing the specified secondary outcomes of the six individual measures constituting the composite
- To assess the cost-effectiveness of the intervention
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Complications of Surgical and Medical Care: General Terms | Other: Usual care Other: Feedback of Performance Other: Feedback of Performance + Health Psychology Informed Intervention | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 262 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Prevention |
Official Title: | Effective Feedback to Improve Primary Care Prescribing Safety (EFIPPS): a Randomised Controlled Trial Using ePrescribing Data |
Study Start Date : | June 2012 |
Actual Primary Completion Date : | October 2013 |
Actual Study Completion Date : | October 2013 |
Arm | Intervention/treatment |
---|---|
Placebo Comparator: Usual care |
Other: Usual care
Practices in the usual care arm receive a one-off educational newsletter and support for searching for patients in their electronic health record in the form of downloadable searches |
Active Comparator: Usual care + feedback of practice performance |
Other: Feedback of Performance
Usual care (educational newsletter and support for searching) plus quarterly feedback of practice rates of high risk prescribing compared to a benchmark of the upper quartile of all practices in the year before |
Active Comparator: Usual care + feedback + health psychology intervention |
Other: Feedback of Performance + Health Psychology Informed Intervention
Usual care (educational newsletter + support for searching) plus quarterly feedback plus health psychology informed intervention (persuasive communication and action planning) embedded in feedback |
- Composite measure of proportion of patients at risk of an adverse event from specified prescribing. [ Time Frame: Change in proportion of patients prescribed a high risk drug between baseline and 12 months after the intervention ]The primary outcome is a composite of six high-risk prescribing measures relating to antipsychotic, non-steroidal anti-inflammatory and antiplatelet drug use. It is defined as the proportion of patients particularly at risk of an adverse event from the specified prescribing, who receives one or more high risk prescriptions. A composite is reasonable because each of the underlying indicators is based on evidence of harm and has been judged valid in one or more formal consensus studies, so the composite is a coherent measure of 'high-risk prescribing'.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- General medical practices in NHS Ayrshire and Arran, NHS Lanarkshire and NHS Lothian
Exclusion Criteria:
- Practices with <250 registered patients
- Practices with <93% of scripts in the new PIS data warehouse having a unique patient identifier (the Community Health Index [CHI] number)
- Practices which were formed after 1st January 2011
- Practices which cease to exist during the trial
- Practices which merge during the trial, where the merging practices were originally in different arms of the trial

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01602705
United Kingdom | |
NHS National Services Scotland | |
Edinburgh, United Kingdom |
Principal Investigator: | Bruce Guthrie | Professor of Primary Care |
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Bruce Guthrie, Professor of Primary Care Medicine, University of Dundee |
ClinicalTrials.gov Identifier: | NCT01602705 |
Other Study ID Numbers: |
2010PS06 |
First Posted: | May 21, 2012 Key Record Dates |
Last Update Posted: | October 7, 2014 |
Last Verified: | October 2014 |
Feedback (NOT MESH) Medication errors Medication review Inappropriate medication |
Randomised controlled trial Primary Health Care Family Practice |